Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. - Wikidata - wikimedia - TriplyDB

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

http://www.wikidata.org/entity/Q33991547

about

A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease Genetic susceptibility to ischemic stroke.Fabry disease and the skin: data from FOS, the Fabry outcome survey.Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey.Unravelling the genetics of ischaemic stroke.Genetics of atherothrombotic and lacunar stroke Idiopathic small fiber neuropathy: phenotype, etiologies, and the search for fabry disease Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy Lipid profile in adult patients with Fabry disease - Ten-year follow up Stroke and Fabry disease.Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke.Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A).Lombardia GENS: a collaborative registry for monogenic diseases associated with stroke.Clinical course and treatment of vertebrobasilar dolichoectasia: a systematic review of the literature.FabryScan: a screening tool for early detection of Fabry disease.High incidence of later-onset fabry disease revealed by newborn screening New information on the genetics of stroke.Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications Update on role of agalsidase alfa in management of Fabry disease.Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).Cerebral hemodynamics and endothelial function in patients with Fabry disease Fabry disease and early stroke Lessons from everyday stroke care for clinical research and vice versa: comparison of a comprehensive and a research population of young stroke patients A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry disease Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke.Innate and Adaptive Immune Response in Fabry Disease Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia.Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study Voxel based analyses of diffusion tensor imaging in Fabry disease.A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation Homocysteine and erythrocyte sedimentation rate correlate with cerebrovascular disease in fabry disease.Brainstem involvement as a cause of central sleep apnea: pattern of microstructural cerebral damage in patients with cerebral microangiopathy.A Case of Cerebral Aneurysmal Subarachnoid Hemorrhage in Fabry's Disease Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.Monogenic vessel diseases related to ischemic stroke: a clinical approach.Childhood arterial ischemic stroke: a review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research.

P2860

Q28478586-A6FB3D33-0E24-4203-8444-3D8D12CF44C5 Q28535031-0B7290FD-4175-49FE-982F-F45764ADB2B7 Q30414709-E0E63A9D-7AC7-4F22-94D2-898E5FB3E68E Q31116015-62DC34A4-2670-4335-A50A-C53592F1DEF0 Q31154163-D28292E8-3D26-461F-AA73-884E5BBD56B2 Q33538069-4E2E0456-3C77-46A7-BEE5-4EC16E831279 Q33557583-51883C8B-6EA2-496C-B73C-DE1FABF8FBBB Q33594744-EFC3C737-8E6A-4D57-B45D-63AE880EE1FB Q33847189-4192121A-32BB-474C-AB06-38CDED25F4FE Q33904518-216B1298-AED0-48CC-B263-5D7D765994F2 Q34061632-FEC963B3-CAD1-4BFD-92E7-EF0B0829E0FB Q34087922-72978A90-A06B-483A-9228-8201A40A15B9 Q34469605-AEC4D39D-E7E5-4FFC-9C2D-C81FA7E0DC35 Q34480067-1AD86B48-884C-451E-A0F4-947F5AC2B48A Q34604516-8D05F42D-2953-4885-886C-5178A7F37D38 Q34641339-1E657F86-4885-4AEB-97BA-2EE99690AE26 Q34658483-FA94004A-3335-469A-B8EF-3E916D99E616 Q34664010-008E264F-D610-4F4C-9E01-17504F518B7B Q34805283-7A0B6B0E-B7F0-4806-8AB5-AA0BF8779011 Q34883178-EEA7210F-29D4-40D4-B520-6FABFDB02956 Q34971549-0545DE29-D212-4C0B-A58A-8FCC13D2588D Q34981327-03145063-D622-4E9E-BE30-F036620DABA5 Q34993215-5A8C1DE9-2BB1-4069-A089-2DE54DDF7F21 Q35037435-6A34EF64-BEF5-4190-AFE7-CD0C0358C79F Q35110216-A0784954-1F11-4F1D-BE02-92EC84111E08 Q35114204-012A0F32-F454-47D0-ABC5-E21E01069278 Q35207863-A89D9F2B-0176-452A-AEB4-648DF007D2C2 Q35608416-907B5E03-739F-4947-A263-0A6458A85C28 Q35754682-263B4598-1006-4332-8621-AFC13BC94F24 Q35800976-5C3F84C6-A8E2-42F8-BE3F-BE772EDBD20D Q35865045-9343CAD6-6F67-42FB-A660-018729E9C0BB Q36177472-0CC889CC-A78B-4EF3-B712-2C8E7E0B3F4F Q36227485-01767CB1-FA5D-453F-8E59-6116CBD7BBCA Q36272033-D3E927CB-9D69-4DE7-99CE-E51FD3C19793 Q36590911-2C65FF27-B054-48AC-9998-DF5347D44B20 Q36789130-BA01E2DB-B988-4F2B-BD92-CA4FD6F76F94 Q36800876-4D6F7216-321E-483B-B689-5E3D01C7B86A Q36819212-D153E6DE-7D95-4B8E-8156-596EA15D3059 Q36853643-05F1C8FE-7572-4FF0-8308-CCDE8EF372D3 Q36921338-E39182E3-4CC6-4618-9966-A76F1B5A3BB6

P2860

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

http://www.wikidata.org/entity/Q33991547

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

@ast

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

@en

type

label

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

@ast

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

@en

prefLabel

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

@ast

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

@en

P1433

Q33991547-F0E1F7C0-9DAA-4C99-BBAE-537BCCA61743

P1476

Q33991547-23892C3A-7002-4015-8F14-DC5713E398A5

P2093

Q33991547-2799AA0D-2047-4078-A52A-841AADA36E42

Q33991547-2BCD21BD-CC74-493A-A139-B29E24ABA149

Q33991547-4A6F2A25-31FA-4E71-A0E0-03EE3951B137

Q33991547-5E45EE60-7F18-466F-9FB7-16BA75CE57E3

Q33991547-6B6CFC65-A78F-4437-999E-8A24F7E972F2

Q33991547-790487D0-7DA6-4FF1-8684-983446B39A90

Q33991547-7F6599C9-F8C6-4FEC-BA86-72BA4B51B247

Q33991547-9114133C-6C92-42F8-8464-A4C1BF2D932A

Q33991547-B654048A-70FA-4610-967A-D0C9BA90FB03

Q33991547-C51C3810-6B3C-4B97-8843-4E2FE41FC388

P304

Q33991547-54AABC83-2952-437A-B422-9D70ABBAD086

P31

Q33991547-06A8528B-DB1B-4953-9B13-E8EDC2672487

P356

Q33991547-23562DE2-CECF-4D89-A10C-A4E7DC84DDB7

P407

Q33991547-8C995C6F-FC1D-40B7-A691-5A9ABAD2E23C

P433

Q33991547-9B17407D-30DB-4EA6-8117-A25E8D7EB42E

P478

Q33991547-07ACFC65-FBEB-4160-BA2C-258FE9D0805A

P50

Q33991547-40CABB77-561C-4922-8B81-B45ECFBBB003

Q33991547-4C8573AD-D683-443E-ABA8-1BE2943761EE

Q33991547-C34643A5-786D-4929-9D3B-146A9E2B7118

Q33991547-D31CE560-60CF-4A9B-B1F2-53FCD266360B

P577

Q33991547-A5BB0A77-8F9C-435F-B74A-D1CE9089A949

P698

Q33991547-ACCF4232-15B5-467F-B94D-6BD16AAE2DB1

P356

S0140-6736(05)67635-0

P1433

P1476

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study

@en

P2093

Annette Grossmann

http://www.w3.org/2001/XMLSchema#string

Arndt Rolfs

http://www.w3.org/2001/XMLSchema#string

Bryan Winchester

http://www.w3.org/2001/XMLSchema#string

Eilhard Mix

http://www.w3.org/2001/XMLSchema#string

Klaus Harzer

http://www.w3.org/2001/XMLSchema#string

Marlies Zschiesche

http://www.w3.org/2001/XMLSchema#string

Peter Bauer

http://www.w3.org/2001/XMLSchema#string

Peter Morris

http://www.w3.org/2001/XMLSchema#string

Reiner Benecke

http://www.w3.org/2001/XMLSchema#string

Tobias Böttcher

http://www.w3.org/2001/XMLSchema#string

P304

1794-1796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(05)67635-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

9499

http://www.w3.org/2001/XMLSchema#string

P478

366

http://www.w3.org/2001/XMLSchema#string

P50

Johannes-Matthias Löhr

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16298216

http://www.w3.org/2001/XMLSchema#string